Flipping the oncogene switch: Illumination of tumor maintenance and regression

Trends in Genetics

Volumn 16, Issue 4, 2000, Pages 147-150

  Chin, Lynda ^a   DePinho, Ronald A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; TETRACYCLINE; VASCULOTROPIN;

CARCINOGENESIS; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE MUTATION; GENETIC DISORDER; HUMAN; MELANOMA; ONCOGENE; PRIORITY JOURNAL; SHORT SURVEY; SOLID TUMOR; SYMBIOSIS; TRANSGENE; TUMOR;

EID: 0034175962     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(99)01968-X     Document Type: Short Survey

References (22)

1. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
2. H. Symonds p53-dependent apoptosis suppresses tumor growth and progression in vivo Cell 78 1994 703 711
3. S.D. Morgenbesser p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens Nature 371 1994 72 74
4. P. Sabbatini Essential role for p53-mediated transcription in E1A-induced apoptosis Genes Dev 9 1995 2184 2192
5. N.W. Kim Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
6. C.M. Counter Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization Proc. Natl. Acad. Sci. U. S. A. 95 1998 14723 14728
7. R.A. Greenberg Short dysfunctional telomeres impair tumorigenesis in the INK4aΔ2/3 Cancer-prone mouse Cell 97 1999 515 525
8. W.C. Hahn Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468
9. S. Bacchetti Telomere maintenance in tumour cells Cancer Surv. 28 1996 197 216
10. A. Kistner Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice Proc. Natl. Acad. Sci. U. S. A. 93 1996 10933 10938
11. D. Ewald Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen Science 273 1996 1384 1386
12. L. Chin Essential role for oncogenic Ras in tumour maintenance Nature 400 1999 468 471
13. L. Chin Cooperative effects of INK4a and ras in melanoma susceptibility in vivo Genes Dev. 11 1997 2822 2834
14. J. Rak Oncogenes as inducers of tumor angiogenesis Cancer Metastasis Rev. 14 1995 263 277
15. J.L. Arbiser Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways Proc. Natl. Acad. Sci. U. S. A. 94 1997 861 866
16. F. Okada Impact of oncogenes in tumor angiogenesis mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells Proc. Natl. Acad. Sci. U. S. A. 95 1998 3609 3614
17. M. Eilers Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells Nature 340 1989 66 68
18. S. Pelengaris Reversible activation of c-myc in skin induction of a complex neoplastic phenotype by a single oncogenic lesion Mol. Cell 3 1999 565 577
19. A. Ziegler Sunburn and p53 in the onset of skin cancer Nature 372 1994 773 776
20. D.W. Felsher J.M. Bishop Reversible tumorigenesis by myc in hematopoietic lineages Mol. Cell 4 1999 199 207
21. A. Berns Turning on tumors to study cancer progression Nat. Med. 5 9 1999 989 990
22. C.S. Huettner Reversibility of acute B-cell leukemia induced by BCR/ABL Nat. Genet. 24 2000 57 60